Ascendis Pharma ADR (ASND)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ASND | GH | EXEL | ||
| Company | Ascendis Pharma ADR | Guardant Health Inc | Exelixis Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 198.60 | 106.01 | 43.97 | ||
| High | 209.45 | 109.59 | 44.79 | ||
| Low | 198.60 | 105.68 | 43.95 | ||
| Latest | 208.58 | 108.52 | 44.37 | ||
| Change | +8.08 | +2.56 | +0.36 | ||
| % Change | +4.03% | +2.42% | +0.82% | ||
| Volume | 674,900 | 1,905,600 | 2,055,100 | ||
| 20-Day Average Volume | 636,625 | 2,452,950 | 2,553,470 | ||
| Previous Close | 200.50 | 105.96 | 44.01 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 206.51 | 101.61 | 42.70 | ||
| 20-Day Raw Stochastic | 58.41% | 82.83% | 89.37% | ||
| 20-Day Relative Strength | 52.64 | 69.95 | 61.74 | ||
| Weighted Alpha | +56.34 | +170.07 | +21.65 | ||
| Today's Opinion | 96% Buy | 100% Buy | 88% Buy | ||
| Previous Opinion | 64% Buy | 100% Buy | 88% Buy | ||
| Last Month's Opinion | 100% Buy | 100% Buy | 88% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -0.68% since 11/26/25 | +0.68% since 11/26/25 | +0.36% since 11/26/25 | ||
| Low | 198.30 on 12/03/25 | 103.36 on 12/02/25 | 43.00 on 12/02/25 | ||
| High | 214.79 on 11/28/25 | 109.59 on 12/04/25 | 44.91 on 11/28/25 | ||
| 1-Month | |||||
| %Chg | +0.16% since 11/04/25 | +10.58% since 11/04/25 | +17.07% since 11/04/25 | ||
| Low | 188.07 on 11/13/25 | 88.88 on 11/05/25 | 38.19 on 11/05/25 | ||
| High | 223.18 on 11/17/25 | 112.43 on 11/25/25 | 44.91 on 11/28/25 | ||
| 3-Month | |||||
| %Chg | +5.27% since 09/04/25 | +76.86% since 09/04/25 | +18.70% since 09/04/25 | ||
| Low | 186.05 on 10/20/25 | 53.40 on 09/16/25 | 33.76 on 10/20/25 | ||
| High | 223.18 on 11/17/25 | 112.43 on 11/25/25 | 44.91 on 11/28/25 | ||
| 6-Month | |||||
| %Chg | +20.09% since 06/04/25 | +127.22% since 06/04/25 | +5.09% since 06/04/25 | ||
| Low | 160.86 on 07/29/25 | 40.35 on 08/01/25 | 33.76 on 10/20/25 | ||
| High | 223.18 on 11/17/25 | 112.43 on 11/25/25 | 49.62 on 06/23/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 12,369,845 | 13,355,304 | 11,799,609 | ||
| Shares Outstanding, K | 61,695 | 126,041 | 268,112 | ||
| Annual Sales | 393,500,000 | 739,020,000 | 2,168,700,000 | ||
| Annual Net Income | -409,120,000 | -436,370,000 | 521,270,000 | ||
| Last Quarter Sales | 249,720,000 | 265,200,000 | 597,760,000 | ||
| Last Quarter Net Income | -71,290,000 | -92,730,000 | 193,580,000 | ||
| 60-Month Beta | 0.45 | 1.58 | 0.40 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -1.17 on 11/12/25 | -0.39 on 10/29/25 | 0.78 on 11/04/25 | ||
| Latest Earnings Date | 11/12/25 | 10/29/25 | 11/04/25 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 18.64 | ||